Monday, November 21, 2011 9:01:58 AM
Edwards Lifesciences had its price target lowered by analysts at Goldman Sachs to $86.00.
Edwards Lifesciences was given a reiterated “buy” by analysts at Jefferies. The analysts now have a $92.00 price target on the stock.
Edwards Lifesciences was given a reiterated “overweight” by analysts at Piper Jaffray. The analysts now have a $83.00 price target on the stock.
Edwards Lifesciences was upgraded by analysts at Lazard Capital from a “neutral” rating to a “buy” rating.
Edwards Lifesciences was given a reiterated “market perform” by analysts at Rodman & Renshaw.
About Edwards Lifesciences:
Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat advanced cardiovascular disease. The Company is focused specifically on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease are categorized into four areas: Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular. The Company operates in United States, Europe, Japan and others. In March 2011, the Company completed the acquisition of Embrella Cardiovascular, Inc. During year ended December 31, 2010, the Company discontinued its MONARC transcatheter mitral valve program
Shares of Edwards Lifesciences opened at 63.02 on Friday. Edwards Lifesciences has a 52 week low of $61.63 and a 52 week high of $91.82. The stock’s 50-day moving average is $73.01 and its 200-day moving average is $81.1. The company has a market cap of $7.189 billion and a price-to-earnings ratio of 32.02.
Recent EW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 12:17:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 09:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 10:06:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 11:10:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:34:20 PM
- Edwards Lifesciences Completes Sale of Critical Care • Business Wire • 09/03/2024 08:30:00 PM
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves • Business Wire • 08/31/2024 10:58:00 PM
- First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves • Business Wire • 08/31/2024 04:35:00 PM
- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference • Business Wire • 08/21/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 11:42:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/20/2024 09:12:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:33:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:58:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/14/2024 08:19:52 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/31/2024 08:20:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 08:14:58 PM
- Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5% • IH Market News • 07/25/2024 10:19:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:26:30 PM
- Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix • Business Wire • 07/24/2024 08:15:00 PM
- Edwards Lifesciences Reports Second Quarter Results • Business Wire • 07/24/2024 08:15:00 PM
- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024 • Business Wire • 07/17/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 01:04:03 PM
- Edwards Lifesciences to Acquire Innovalve • Business Wire • 07/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:38:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 08:17:18 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM